semaglutide essence study Phase 3 Trial of in Metabolic Dysfunction–Associated Steatohepatitis Semaglutide targets MASH molecular pathways – Diabetes Dialogue: Semaglutide for MASH

Some people find they lose more weight when adding B12, especially if they had a B12 deficiency before starting

Injection technique is reducing bioavailability How you inject affects how much medication your body actually absorbs

In a clinical trial, patients taking Wegovy at the 2.4mg dose lost around 15 to 17% of their body weight over 68 weeks [1]

Mounjaro (generic name tirzepatide) is whats called a dual-agonist medication

Association of GLP-1 Receptor Agonists With Gastrointestinal Adverse Events . JAMA , 2023

Some signs that require medical attention include: Frequent heartburn (more than twice a week) Regurgitation (food or stomach acid coming back up into the throat) Persistent nausea or vomiting Chest pain that does not improve with antacids Difficulty swallowing or feeling like food is stuck in the throat Unexplained weight loss that is not due to the intended effects of semaglutide Doctors can assess symptoms and determine if they are caused by semaglutide, GERD, or another condition